Impact of obesity on catheter ablation of ventricular tachycardia : In-hospital and 30-day outcomes

© 2023 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Heart Rhythm Society..

Background: Evidence on the impact of obesity on catheter ablation for ventricular tachycardia (VT) is scarce.

Method and Results: We queried the Nationwide Readmissions Database to determine the hospital outcomes and procedural complications of VT ablation among the obese and nonobese populations. Obesity was associated with a more prolonged length of stay (p < .01), higher cost of hospitalization (p < .01), and higher rates of pericardial effusion or hemopericardium (p = .05) and vascular complications (p = .05). There was no significant difference in early mortality, 30-day readmissions, and other procedural complications.

Conclusion: VT ablation could be performed relatively safely among patients with obesity.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:39

Enthalten in:

Journal of arrhythmia - 39(2023), 4 vom: 14. Aug., Seite 672-675

Sprache:

Englisch

Beteiligte Personen:

Tan, Min Choon [VerfasserIn]
Yeo, Yong Hao [VerfasserIn]
Ang, Qi Xuan [VerfasserIn]
Tan, Bryan E-Xin [VerfasserIn]
Rattanawong, Pattara [VerfasserIn]
Tan, Jian Liang [VerfasserIn]
Lee, Justin Z [VerfasserIn]

Links:

Volltext

Themen:

Catheter ablation
In‐hospital outcomes
Journal Article
Obesity
Procedural complications
Ventricular tachycardia

Anmerkungen:

Date Revised 11.08.2023

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1002/joa3.12892

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360598811